Largestever Ozempic and GLP1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
Jan 20, 2025
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 receptor agonists. Read More
https://fortune.com/well/article/ozempic-glp1-study-lower-risk-42-health-conditions-heart-attack-alzheimers/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service